Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bruce Berkowitz’s St. Joe (JOE) Investment

Bruce Berkowitz of Fairholme Capital is going to present at the Harbor Investment Conference this week from New York City, and some are speculating that he could announce a potential transaction regarding St. Joe (NYSE: JOE) at the conference.

Personally, I don’t think he will announce anything major at the conference, like a full takeover of the company, but perhaps he will lay out his thesis on what he believes the company is worth, similar to what David Einhorn of Greenlight Capital did at the Value Investing Congress in October.

FAIRHOLME (FAIRX) Bruce Berkowitz

Some have said that Einhorn is wrong on this name, despite saying that the company was only worth $7-$10 per share. Shares are far higher than that today, trading around the $27 level, and are higher than when Einhorn discussed it during his presentation. Shares of JOE initially spiked down after Einhorn first revealed his short position in St. Joe, but are now above that October level.

Real estate in Florida is starting to recover, slowly but surely, and over time, the company will be worth far more than what Einhorn says it’s worth. That’s just the nature of real estate.

Perhaps the company will have to take some writedowns for its land, as per the SEC inquiry, but I suspect it won’t be nearly as much as Einhorn thinks.

This has been a battle of the industry titans for some time, and investors will be hanging on to see what Berkowitz has to say on Thursday.

This article is originally published at Benzinga.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!